4.7 Article

Searching for the Predictors of Response to BoNT-A in Migraine Using Machine Learning Approaches

Journal

TOXINS
Volume 15, Issue 6, Pages -

Publisher

MDPI
DOI: 10.3390/toxins15060364

Keywords

migraine; machine learning; onabotulinumtoxinA; predictors of efficacy

Ask authors/readers for more resources

This study used machine learning algorithms to predict treatment response to OnabotulinumtoxinA (BonT-A) in patients with migraine. The results showed that none of the clinical characteristics could distinguish responders from nonresponders in the chronic migraine group, while a pattern of four features (age at onset of migraine, opioid use, anxiety subscore, and Migraine Disability Assessment score) correctly predicted response in high-frequency episodic migraine.
OnabotulinumtoxinA (BonT-A) reduces migraine frequency in a considerable portion of patients with migraine. So far, predictive characteristics of response are lacking. Here, we applied machine learning (ML) algorithms to identify clinical characteristics able to predict treatment response. We collected demographic and clinical data of patients with chronic migraine (CM) or high-frequency episodic migraine (HFEM) treated with BoNT-A at our clinic in the last 5 years. Patients received BoNT-A according to the PREEMPT (Phase III Research Evaluating Migraine Prophylaxis Therapy) paradigm and were classified according to the monthly migraine days reduction in the 12 weeks after the fourth BoNT-A cycle, as compared to baseline. Data were used as input features to run ML algorithms. Of the 212 patients enrolled, 35 qualified as excellent responders to BoNT-A administration and 38 as nonresponders. None of the anamnestic characteristics were able to discriminate responders from nonresponders in the CM group. Nevertheless, a pattern of four features (age at onset of migraine, opioid use, anxiety subscore at the hospital anxiety and depression scale (HADS-a) and Migraine Disability Assessment (MIDAS) score correctly predicted response in HFEM. Our findings suggest that routine anamnestic features acquired in real-life settings cannot accurately predict BoNT-A response in migraine and call for a more complex modality of patient profiling.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available